Efeito de PereSkin, uma formulação contendo extrato de Pereskia aculeata Miller, no tratamento de dermatite atópica induzida em ratos
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Atopic dermatitis (AD) is a chronic, allergic and recurrent disease that
affects 1 to 20% of the world’s population, including adults and children, whose
increasing incidence follows industrialization levels in different countries. Its
manifestation usually begins during the early childhood, along with other allergic
diseases such as asthma, rhinitis and allergic conjunctivitis, as a consequence of the
atopic march. Similarly, AD can affect dogs, and the canine atopic dermatitis (CAD) is
currently the second most common veterinary dermatopathy presented in clinical
animal health, making the disease a growing concern in the health area. The currently
most accepted theory for its development involves a set of intrinsec and extrinsic
factors, of both immunological and non-immunological nature. Immunological
responses involves a type I hypersensitivity mediated by IgE while trophic disturbances
involving the expression of epithelial proteins result in skin barrier disruption.
Terapeutic approach for this condition includes maintenance of the skin barrier, aiming
to reduce transepidermal water loss (TEWL), exposure to allergens and the
consequent inflammatory response. In this scenario, the species Pereskia aculeata is
a Cactaceae used in brazilian tradicional medicine whose leaves are used as an
emollient agent due to heir mucilaginous content, in order to reduce inflammatory
processes associated with many skin diseases. This work aimed to evaluate the effects
of an extract rich in polyssacharides obtained from the leaves of P. aculeata wich was
incorporated into a hypoallergenic formulation named PereSkin, used in the topical
treatment of an animal model of AD induced by capsaicin in Wistar rats, in two different
time points of continuos treatment, for 2 and 4 weeks. Clinical evaluations carried out
throughout the experiment indicated that the use of PereSkin is associated with a
reduction in the dermatitis score, corroborated histopathological and morfometric
evaluations, showing a reduction in epidermal thickness in addition to a decrease in
associated morphological alterations. Histochemical analyzes showed a reduction in
the dermis infiltrated of mast cells. Taken together, these observations sugest that
PereSkin exerts anti-inflammatory activitie, helping on the skin barrier restitution and
reducing the AD associated symptoms, and may be useful in the coadjuvant topical
treatment and in the maintenance therapy of AD patients.
Description
Keywords
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

